Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

2016 LTIP Awards - Replacement

30 Jun 2016 17:10

RNS Number : 8814C
Kainos Group plc
30 June 2016
 

 

 

The following amendment(s) have been made to the '2016 LTIP Awards' announcement released on30 June 2016 at 16.25 under RNS No 8717C.

 

Brian Gannon, Corporate Development Director has 50,000 shares and Grainne Burns, Company Secretary has 32,052 shares.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

 

30 June 2016

 

Kainos Group plc

 

("Kainos" or the "Company)

2016 LTIP Awards

The Company announces that on 23 June 2016 share awards (the "Awards") approved by the Board of Directors of the Company under the Kainos Group Performance Share Plan (the "PSP"), in the form of nominal value options over ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") were awarded to Executive Directors and PDMRs of the Company.

Awards have been granted to the three Executive Directors and two PDMRs, over a total of 250,962 ordinary shares.

Name

Title

Number of Shares

Brendan Mooney

CEO

56,410

Richard McCann

CFO/COO

62,500

Paul Gannon

Sales Director

50,000

Brian Gannon

Corporate Development Director

50,000

Grainne Burns

Company Secretary

32,052

Performance Conditions and Vesting of Awards

Awards will be subject to the rules of the PSP and the following conditions:

(i) Fifty per cent (50%) of the Award will be subject to earnings per share ("EPS") percentage growth target, over a three-year period up to the financial year ending 31 March 2019.

 

EPS Growth % of Award vesting

9% 30%

>9% but

≥16% 100%

(ii) Fifty per cent (50%) of the Award will be subject to total shareholder return ("TSR") performance condition, over a three-year period from date of grant.

TSR Growth % of Award vesting

9% 30%

>9% but

≥16% 100%

The number of shares subject to the Award was determined by using the average mid-market price for the 3 trading days before the date of the Award, this was 156.2p.

Timetable

Awards are expected to vest in June 2019, following the announcement of the Company's results for the year ended 31 March 2019 and completion of the TSR Growth measurement period.

Ends

 

For further information, please contact

Kainos

via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

 

Brian Gannon, SVP Corporate Development

 

 

 

Investec Bank plc

+44 (0) 20 7597 5970

Dominic Emery / Sebastian Lawrence

Patrick Robb / Matt Lewis

 

 

 

FTI Consulting LLP

+44 (0) 20 3727 1000

Matt Dixon / Chris Lane

 

 

Notes to Editors

Kainos Group plc is a high-growth UK-based provider of IT services, consulting and software solutions, specialising across multiple sectors in the development of digital technology solutions. These include software design and agile software development, third-party software integration and implementation services, technology support services and related ancillary services such as project management.

 

Kainos operates through three divisions: Digital Services, which delivers full system developments of customised online digital solutions; Evolve, the UK market leader in the digitisation of patient notes in the Acute sector of the NHS; and Workday Implementation Services, the only boutique partner for Workday, Inc. headquartered in the UK, responsible for implementing Workday's innovative Software-as-a-Service platform for enterprise customers.

 

Headquartered in Belfast, Northern Ireland, Kainos employs approximately 750 staff across seven offices (Belfast, Derry, Dublin, London, Bristol, Gdansk and Boston). Kainos is listed on the Main Market of the London Stock Exchange (KNOS). For further information please visit the company website: https://www.kainos.com/ 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDLXGXBGLG
Date   Source Headline
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast
1st Aug 20234:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.